Metraipolis › archive › dc_06f85d66cc2f

Structure-based development of 3,5-dihydroxybenzoyl-hydrazineylidene as tyrosinase inhibitor; in vitro and in silico study — Europe PMC PMID:38233558

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/38233558
DOI
10.1038/s41598-[numero omesso]-6
License (as archived)
solo-consultazione
Archived
2026-10-08T03:01:07.205Z
SHA-256 of the archived text
cfbd85391ed2ced42c2518fa08040c8eb16e497ba5cce5bad53df77084260161
Stable URL of this page
https://metraipolis.com/documento/dc_06f85d66cc2f

How to cite

Structure-based development of 3,5-dihydroxybenzoyl-hydrazineylidene as tyrosinase inhibitor; in vitro and in silico study — Europe PMC PMID:38233558 — Europe PMC (en), https://europepmc.org/article/MED/38233558 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_06f85d66cc2f (Metraipolis archive dc_06f85d66cc2f, sha256 cfbd85391ed2ced42c2518fa08040c8eb16e497ba5cce5bad53df77084260161)
BibTeX
@misc{dc06f85d66cc2f,
  title = {Structure-based development of 3,5-dihydroxybenzoyl-hydrazineylidene as tyrosinase inhibitor; in vitro and in silico study — Europe PMC PMID:38233558},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/38233558},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_06f85d66cc2f; sha256 cfbd85391ed2ced42c2518fa08040c8eb16e497ba5cce5bad53df77084260161},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/38233558. Agents can read the archived copy with the MCP tool read_document.